Earnings Call · Q1 FY2026·2026-05-07

Q1 26EPS +100.00%*·Rev n/aQ4 25EPS +100.00%*·Rev n/aQ3 25EPS +71.43%·Rev n/aQ2 25EPS +100.00%*·Rev n/a⚠ consensus missing

10x Genomics, Inc. TXG

Cassie Corneau — Investor Relations

Serge Saxonov — Chief Executive Officer

Adam Taich — Chief Financial Officer

−3.7%1d on move date−4.5% vs SPY3d−6.7%5d−4.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TXG calls or request research access.

More TXG calls Browse calls Request research access